Cargando…
Development, Evaluation, and Implementation of a House-Made Targeted Next-Generation Sequencing Spoligotyping in a French Laboratory
Epidemiological studies investigating transmission chains of tuberculosis are undertaken worldwide to tackle its spread. CRISPR locus diversity, called spoligotyping, is a widely used genotyping assay for Mycobacterium tuberculosis complex (MTBC) characterization. Herein, we developed a house-made t...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569608/ https://www.ncbi.nlm.nih.gov/pubmed/36232601 http://dx.doi.org/10.3390/ijms231911302 |
_version_ | 1784809896489779200 |
---|---|
author | Genestet, Charlotte Baffert, Yannick Vallée, Maxime Bernard, Albin Benito, Yvonne Lina, Gérard Hodille, Elisabeth Dumitrescu, Oana |
author_facet | Genestet, Charlotte Baffert, Yannick Vallée, Maxime Bernard, Albin Benito, Yvonne Lina, Gérard Hodille, Elisabeth Dumitrescu, Oana |
author_sort | Genestet, Charlotte |
collection | PubMed |
description | Epidemiological studies investigating transmission chains of tuberculosis are undertaken worldwide to tackle its spread. CRISPR locus diversity, called spoligotyping, is a widely used genotyping assay for Mycobacterium tuberculosis complex (MTBC) characterization. Herein, we developed a house-made targeted next-generation sequencing (tNGS) spoligotyping, and compared its outputs with those of membrane-based spoligotyping. A total of 144 clinical MTBC strains were retrospectively selected to be representative of the local epidemiology. Data analysis of a training set allowed for the setting of “presence”/“absence” thresholds for each spacer to maximize the sensibility and specificity related to the membrane-based spoligotyping. The thresholds above, in which the spacer was considered present, were 50 read per millions for spacers 10 and 14, 20,000 for spacers 20, 21, and 31, and 1000 for the other spacers. The confirmation of these thresholds was performed using a validation set. The overall agreement on the training and validation sets was 97.5% and 93.8%, respectively. The discrepancies concerned six strains: Two for spacer 14, two for spacer 31, and two for spacer 32. The tNGS spoligotyping, whose thresholds were finely-tuned during a careful bioinformatics pipeline development process, appears be a technique that is reliable, inexpensive, free of handling errors, and automatable through automatic transfer into the laboratory computer system. |
format | Online Article Text |
id | pubmed-9569608 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95696082022-10-17 Development, Evaluation, and Implementation of a House-Made Targeted Next-Generation Sequencing Spoligotyping in a French Laboratory Genestet, Charlotte Baffert, Yannick Vallée, Maxime Bernard, Albin Benito, Yvonne Lina, Gérard Hodille, Elisabeth Dumitrescu, Oana Int J Mol Sci Article Epidemiological studies investigating transmission chains of tuberculosis are undertaken worldwide to tackle its spread. CRISPR locus diversity, called spoligotyping, is a widely used genotyping assay for Mycobacterium tuberculosis complex (MTBC) characterization. Herein, we developed a house-made targeted next-generation sequencing (tNGS) spoligotyping, and compared its outputs with those of membrane-based spoligotyping. A total of 144 clinical MTBC strains were retrospectively selected to be representative of the local epidemiology. Data analysis of a training set allowed for the setting of “presence”/“absence” thresholds for each spacer to maximize the sensibility and specificity related to the membrane-based spoligotyping. The thresholds above, in which the spacer was considered present, were 50 read per millions for spacers 10 and 14, 20,000 for spacers 20, 21, and 31, and 1000 for the other spacers. The confirmation of these thresholds was performed using a validation set. The overall agreement on the training and validation sets was 97.5% and 93.8%, respectively. The discrepancies concerned six strains: Two for spacer 14, two for spacer 31, and two for spacer 32. The tNGS spoligotyping, whose thresholds were finely-tuned during a careful bioinformatics pipeline development process, appears be a technique that is reliable, inexpensive, free of handling errors, and automatable through automatic transfer into the laboratory computer system. MDPI 2022-09-25 /pmc/articles/PMC9569608/ /pubmed/36232601 http://dx.doi.org/10.3390/ijms231911302 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Genestet, Charlotte Baffert, Yannick Vallée, Maxime Bernard, Albin Benito, Yvonne Lina, Gérard Hodille, Elisabeth Dumitrescu, Oana Development, Evaluation, and Implementation of a House-Made Targeted Next-Generation Sequencing Spoligotyping in a French Laboratory |
title | Development, Evaluation, and Implementation of a House-Made Targeted Next-Generation Sequencing Spoligotyping in a French Laboratory |
title_full | Development, Evaluation, and Implementation of a House-Made Targeted Next-Generation Sequencing Spoligotyping in a French Laboratory |
title_fullStr | Development, Evaluation, and Implementation of a House-Made Targeted Next-Generation Sequencing Spoligotyping in a French Laboratory |
title_full_unstemmed | Development, Evaluation, and Implementation of a House-Made Targeted Next-Generation Sequencing Spoligotyping in a French Laboratory |
title_short | Development, Evaluation, and Implementation of a House-Made Targeted Next-Generation Sequencing Spoligotyping in a French Laboratory |
title_sort | development, evaluation, and implementation of a house-made targeted next-generation sequencing spoligotyping in a french laboratory |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569608/ https://www.ncbi.nlm.nih.gov/pubmed/36232601 http://dx.doi.org/10.3390/ijms231911302 |
work_keys_str_mv | AT genestetcharlotte developmentevaluationandimplementationofahousemadetargetednextgenerationsequencingspoligotypinginafrenchlaboratory AT baffertyannick developmentevaluationandimplementationofahousemadetargetednextgenerationsequencingspoligotypinginafrenchlaboratory AT valleemaxime developmentevaluationandimplementationofahousemadetargetednextgenerationsequencingspoligotypinginafrenchlaboratory AT bernardalbin developmentevaluationandimplementationofahousemadetargetednextgenerationsequencingspoligotypinginafrenchlaboratory AT benitoyvonne developmentevaluationandimplementationofahousemadetargetednextgenerationsequencingspoligotypinginafrenchlaboratory AT linagerard developmentevaluationandimplementationofahousemadetargetednextgenerationsequencingspoligotypinginafrenchlaboratory AT hodilleelisabeth developmentevaluationandimplementationofahousemadetargetednextgenerationsequencingspoligotypinginafrenchlaboratory AT dumitrescuoana developmentevaluationandimplementationofahousemadetargetednextgenerationsequencingspoligotypinginafrenchlaboratory |